The basis

The basis LGK-974 nmr of travel medicine was to try to decrease the risks of disease and injury for individual travelers when visiting environments perceived as having excess health risks compared to the home country. Owing to economic growth in large parts of Asia, the number of outbound travelers from this region is dramatically increasing. In 1990, only 50 million Asians traveled abroad, while this number reached 100 million in the year 2000 and 190 million in 2010.[1] The outbound tourism growth rate among Asian travelers is the highest in

the world. Thus, travelers from Asia are becoming a major proportion of world tourism. In 1980 less than 10% of international travelers were from Asia. This proportion doubled in 2010 and it is expected to reach

30% in 2030, equal to 500 million.[1] So far, the concept of travel medicine is not well known in Asia among both travelers and health care professionals. Only 21% to 40% of Asian travelers sought pre-travel health information before their trip;[2-4] this proportion being far lower as compared to 60% to 80% in “Western” travelers.[5, 6] Recent evidence is even more concerning; only 4% of Chinese travelers who traveled to high malaria risk areas visited a travel clinic before their trip,[7] and only 5% of Japanese travelers who traveled to developing Vincristine in vitro countries received hepatitis A vaccine.[2] These rates were far lower than among European travelers.[6] Using the clinic directory of the International Society of

Travel Medicine (ISTM) as a crude indicator, very 3-mercaptopyruvate sulfurtransferase few travel medicine services have been established in Asia. While one travel clinic in North America serves 220,000 people, in Asia it may have to serve up to 45 million people. It should be noted that the European data are partly misleading, as many countries have highly developed national travel health associations and thus few travel clinic staff apply for membership in ISTM. However, this does not apply to North America, Australia, or Asia. There may be several reasons for the apparent lack of awareness and interest of travelers or health professionals in regard to travel health risks in Asia: The perception of risk. Pre-travel medicine in “Western” countries is mainly focused on diseases that may have become rare, have been eradicated or never existed in their home countries, but remain endemic in large parts of Asia, such as malaria, typhoid, hepatitis A, hepatitis B, dengue, rabies, and Japanese encephalitis (JE). Doctors and travelers from Asia who are familiar with these diseases usually consider that there is no additional risk for these diseases when traveling within Asia.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>